, and the balance at the end of the first quarter of the fiscal year 2017 accounted for 45 percent of the total assets and is thus considered EARTH's core assets. Accurate and complete information on such
Healthcare Center Co.,, Ltd. - a subsidiary of the Company and Wuttisak Clinic Inter Group Co., Ltd. – an indirect subsidiary of E FOR L Aim Public Co., Ltd. had been complete; and further progress shall be
growth driven by lifestyle fibers growth in India (IRSL). IVL reported US$281M of core EBITDA registering a more pronounced decline yoy as spreads came off from a strong 3Q18. IVL reported US$405M of OCF
Quarter 2018 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 1st Quarter 2018 Best Performance Since IPO Core EBITDA of $326 million – 49% increase year-on-year Core
downstream business in Integrated Oxides and Derivatives based out of advantaged Gulf Coast USA. Indorama Ventures 2nd Quarter 2019 MD&A 2 2Q 2019 Summary Financials Table 1: Core Financials of Consolidated
to a 20% reduction in IVL’s core EBITDA. Operating cash flow through this period increased by 33% to $1.3B, as a result of lower prices and operational excellence. IVL has proposed a dividend of
Ventures 1st Quarter 2019 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 1st Quarter 2019 Highlights Revenue $3.0 billion (THB 95.8 billion), +26% YoY Core EBITDA of $304
Indorama Ventures 1st Quarter 2019 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 1st Quarter 2019 Highlights Revenue $3.0 billion (THB 95.8 billion), +26% YoY Core EBITDA
, Structural Improvements, Enhanced Portfolio, New Investment Strategy In 2018: Revenue $10.7 billion, +27% YoY Core EBITDA of $1.4 billion, +44% YoY, Core EBITDA margin 13% Net Profit (after Tax/NCI) of
LTM 3Q18 Revenue $10.1 billion, +24% YoY, Core EBITDA margin 13.7% Core EBITDA of $409m in 3Q18, +40% YoY; $1,379m LTM 3Q18 (45% YoY) LTM 3Q18 Core EPS THB 4.49, +65% post 11.1% dilution from